A case of nonarteritic ischemic optic neuropathy (NAION) in a male patient taking sildenafil

• Published in: International journal of clinical pharmacology and therapeutics Vol. 40; no. 9; p. 422
• Main Authors: Boshier, A, Pambakian, N, Shakir, S A W
• Format: Journal Article
• Language: English
• Published: Germany 01.09.2002
• Subjects: Humans; Male; Middle Aged; Optic Neuropathy, Ischemic - chemically induced; Optic Neuropathy, Ischemic - physiopathology; Piperazines - adverse effects; Product Surveillance, Postmarketing; Purines; Sildenafil Citrate; Sulfones

Sildenafil is a phosphodiesterase-type-5 inhibitor indicated for the treatment of erectile dysfunction in men. We report a case of NAION identified from a cohort of 8,893 patients (from a Prescription-Event Monitoring study) prescribed sildenafil by their primary care physician in England between Ap...